Xponance’s MaxLinear MXL Stock Holding History

Xponance’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,172	Closed	-$314K	–	1185
2021 Q4	$314K	Buy	+4,172	New	+$267K	﹤0.01%	1032

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Xponance's MXL Position: Q1 2022 in Review

Xponance sold out of MaxLinear (MXL) in Q1 2022, closing a stake of 4,172 shares — an estimated $314K sold.

Xponance first reported a position in MXL in Q4 2021 and held it in 1 quarter. The position peaked at $314K in Q4 2021. 293 funds tracked by Wall St. Rank hold MXL as of Q1 2022.

Xponance reported no remaining MaxLinear position as of Q1 2022 after selling out during the quarter.
Xponance sold 4,172 MaxLinear shares in Q1 2022, an estimated $314K.
Xponance first reported a position in MaxLinear in Q4 2021 and held it in 1 quarter.
Xponance's MaxLinear position peaked at $314K in Q4 2021.
293 funds tracked by Wall St. Rank held MaxLinear as of Q1 2022.

Based on Xponance's 13F filing for Q1 2022, filed 20 Apr 2022.